Allarity Therapeutics, Inc. (ALLR)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, Allarity Therapeutics, Inc. reported revenue of $320.0K. The company ran a net loss, with a net margin of -3509.7%. It held $18.26M in total assets against $8.43M in total liabilities.
Key ratios (FY2025)
-3939.1%
Operating margin
-3509.7%
Net margin
-114.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $320.0K | $0 | — | — | — | — | — |
| Gross Profit | — | — | — | -$2.27M | — | — | — |
| Operating Income | -$12.61M | -$27.24M | -$17.13M | -$34.46M | -$26.56M | -$8.32M | — |
| Net Income | -$11.23M | -$24.52M | -$11.90M | -$16.06M | -$26.65M | -$6.62M | — |
| EPS (Diluted) | $-0.78 | $-15.65 | $-6031.31 | $-3093.42 | $-4.19 | $-2.03 | — |
| Total Assets | $18.26M | $22.65M | $11.86M | $14.54M | $49.63M | $33.40M | — |
| Total Liabilities | $8.43M | $10.84M | $14.61M | $12.65M | $30.85M | $8.96M | — |
| Shareholders' Equity | $9.83M | $11.81M | -$2.75M | -$113.0K | $18.15M | $24.44M | $20.04M |
| Cash & Equivalents | $14.69M | $19.53M | $166.0K | $2.03M | — | — | — |
| Operating Cash Flow | -$14.82M | -$17.35M | -$12.74M | -$16.82M | -$14.89M | -$7.25M | — |
| Capital Expenditures | $8.0K | $298.0K | $0 | $18.0K | — | $3.0K | — |
| Shares Outstanding | 16.08M | 7.30M | 9.8K | 11.4K | 8.10M | 4.25M | — |